Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 38Neoplasms 22Motor Activity 12Colorectal Neoplasms 9Lung Neoplasms 8Stomach Neoplasms 7Pain, Postoperative 7Fatigue 7Anxiety Disorders 6Pain 5Carcinoma, Hepatocellular 5Rectal Neoplasms 4Polycystic Ovary Syndrome 4Leukemia, Myeloid, Acute 4Depression 4Colonic Neoplasms 4Thyroid Neoplasms 3Stomatitis 3Squamous Cell Carcinoma of Head and Neck 3Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Malnutrition 3Liver Neoplasms 3Head and Neck Neoplasms 3Agnosia 3Vomiting 2Uterine Cervical Neoplasms 2Urinary Incontinence 2

Interventions

entecavir 9Tenofovir 3Lamivudine 3lenvatinib 2Sorafenib 2Hepatitis B Vaccines 2tenofovir alafenamide 1polysaccharide MGN3 1peginterferon alfa-2b 1navitoclax 1menatetrenone 1lens intermediate filament proteins 1human papillomavirus vaccine, L1 type 16, 18 1adefovir 1Ultrasonography 1Tumor Necrosis Factor-alpha 1Tetanus Toxoid 1Telbivudine 1Standard of Care 1Rapid Diagnostic Tests 1Raltegravir Potassium 1Radiofrequency Ablation 1Practice Guidelines as Topic 1Polymorphism, Genetic 1Pneumococcal Vaccines 1PHY 906 1Nivolumab 1Measles-Mumps-Rubella Vaccine 1Hypothermia, Induced 1Heptavalent Pneumococcal Conjugate Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hepatitis B × Control Groups × Clear all
NCT00824707 2016-04-01

Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer

Eastern Hepatobiliary Surgery Hospital

Phase NA Completed
200 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡